Meet the Speakers
Dr. Nathaniel Simon Treister, D.M.D., D.M.Sc.
Associate Surgeon and Division Chief, Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, Boston, MA, USA
Associate Professor, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA
Dr. Treister is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women's Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity.
He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Boston Children’s Hospital with special interest in oral mucosal diseases, salivary gland diseases, orofacial neuropathic disorders, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of allogeneic hematopoietic cell transplantation and oral graft-versus-host disease. He is co-principal investigator of an NIH R01 grant entitled “Long Term Oral Health Outcomes in the Chronic GVHD Consortium” and serves as site principal investigator for an NIH U01 grant entitled “Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients”.
Sharon Elad, D.M.D., M.Sc.
Professor and Chair, Division of Oral Medicine
Principal Consultant, Hospital Dentistry
Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA
Dr. Elad is a Professor of Dentistry at the University of Rochester, where she is Chair of the Division of Oral Medicine at the Eastman Institute for Oral Health (EIOH), and a Principal Consultant for Hospital Dentistry at University of Rochester Medical Center, Rochester, NY. Dr. Elad is currently the Chair of the MASCC/ISOO Mucositis Study Group (MSG). Dr. Elad is also the section head for GVHD and for Viral Infections in the MASCC/ISOO Oral Care Study Group (OCSG). During the years of service in the MSG and OCSG leadership as well as in the ISOO Board she took a lead role in the development and publication of several guidelines and position papers.
Dr. Elad published extensively in professional journals, co-authored multiple book chapters and is an editorial board member in several medical journals.